TEAD4
Basic information
Region (hg38): 12:2959330-3040676
Previous symbols: [ "TCF13L1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TEAD4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 21 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 23 | 2 | 0 |
Variants in TEAD4
This is a list of pathogenic ClinVar variants found in the TEAD4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-2994819-C-T | not specified | Uncertain significance (Nov 05, 2021) | ||
12-2994854-G-T | not specified | Uncertain significance (Feb 15, 2023) | ||
12-2994897-G-A | not specified | Uncertain significance (Apr 06, 2022) | ||
12-2994932-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
12-2994972-C-T | not specified | Uncertain significance (May 17, 2023) | ||
12-3011006-C-T | not specified | Uncertain significance (Apr 21, 2022) | ||
12-3011024-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
12-3012210-G-C | not specified | Uncertain significance (Nov 27, 2023) | ||
12-3017398-G-C | not specified | Uncertain significance (Mar 01, 2023) | ||
12-3017497-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
12-3017506-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
12-3017510-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
12-3019115-T-C | not specified | Likely benign (Apr 08, 2024) | ||
12-3019147-T-C | not specified | Uncertain significance (Apr 17, 2023) | ||
12-3020630-G-T | Likely benign (Aug 01, 2022) | |||
12-3020652-G-T | not specified | Uncertain significance (Jun 03, 2022) | ||
12-3020657-G-A | not specified | Likely benign (Oct 13, 2021) | ||
12-3020675-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
12-3020693-C-G | not specified | Uncertain significance (Dec 12, 2023) | ||
12-3020705-G-A | not specified | Uncertain significance (Jun 16, 2022) | ||
12-3020768-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
12-3021862-G-A | not specified | Uncertain significance (Jan 19, 2024) | ||
12-3021910-G-T | not specified | Uncertain significance (May 30, 2024) | ||
12-3021923-G-T | not specified | Uncertain significance (Jan 30, 2024) | ||
12-3021980-G-A | not specified | Uncertain significance (Apr 06, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TEAD4 | protein_coding | protein_coding | ENST00000359864 | 11 | 81344 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000323 | 0.988 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.38 | 216 | 281 | 0.768 | 0.0000179 | 2850 |
Missense in Polyphen | 74 | 113.22 | 0.65361 | 1190 | ||
Synonymous | -0.231 | 122 | 119 | 1.03 | 0.00000837 | 831 |
Loss of Function | 2.24 | 11 | 22.4 | 0.490 | 9.56e-7 | 260 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000148 | 0.000148 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000534 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000329 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and epithelial mesenchymal transition (EMT) induction. Binds specifically and non-cooperatively to the Sph and GT-IIC 'enhansons' (5'-GTGGAATGT-3') and activates transcription. Binds to the M-CAT motif. {ECO:0000269|PubMed:18579750, ECO:0000269|PubMed:19324877}.;
- Pathway
- Hippo signaling pathway - Homo sapiens (human);Hippo signaling pathway - multiple species - Homo sapiens (human);Preimplantation Embryo;VEGFA-VEGFR2 Signaling Pathway;miR-509-3p alteration of YAP1-ECM axis;Gene expression (Transcription);RUNX3 regulates YAP1-mediated transcription;Transcriptional regulation by RUNX3;Generic Transcription Pathway;RNA Polymerase II Transcription;YAP1- and WWTR1 (TAZ)-stimulated gene expression
(Consensus)
Recessive Scores
- pRec
- 0.141
Intolerance Scores
- loftool
- rvis_EVS
- 0.35
- rvis_percentile_EVS
- 74.58
Haploinsufficiency Scores
- pHI
- 0.928
- hipred
- hipred_score
- ghis
- 0.473
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.964
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tead4
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype;
Gene ontology
- Biological process
- skeletal system development;regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;muscle organ development;hippo signaling;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;transcription factor complex
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II transcription factor binding;DNA-binding transcription factor activity;protein binding;sequence-specific DNA binding;transcription regulatory region DNA binding